NSC |
Compound |
Enrichment |
Correlation |
NSC 743864 |
Null |
0.00845932736945076 |
0.39907706 |
NSC 718170 |
Null |
0.0112425217758228 |
0.30226846 |
NSC 718728 |
5-[2-(2,5-Dimethoxyphenyl)ethynyl]-2-methoxyphenyl-N- [2-(4-fluorophenyl)ethyl]carboxamide |
0.0112425217758228 |
0.71151682 |
NSC 725191 |
1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol |
0.0112425217758228 |
0.39365887 |
NSC 732317 |
6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide |
0.0112425217758228 |
0.096817001 |
NSC 734977 |
Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate |
0.0112425217758228 |
-0.20399415 |
NSC 749550 |
3-amino-N-(4-benzylphenyl)-5-chloro-1H-indazole-1-carboxamide |
0.0112425217758228 |
0.45621841 |
NSC 756166 |
GSK312948A |
0.0112425217758228 |
0.591702 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0112425217758228 |
0.55790531 |
NSC 12198 |
Dromostanolone Propionate |
0.0112425217758229 |
0.24924944 |